Provided by Tiger Trade Technology Pte. Ltd.

Checkpoint Therapeutics, Inc.

4.26
0.0000
Volume:- -
Turnover:36.86M
Market Cap:356.83M
PE:-3.48
High:4.26
Open:4.26
Low:4.26
Close:4.26
52wk High:4.50
52wk Low:1.80
Shares:83.76M
Float Shares:60.50M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2229
EPS(LYR):-1.4175
ROE:-1869.55%
ROA:-152.73%
PB:21.90
PE(LYR):-3.01

Loading ...

Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 02, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 29, 2024

Correspondence

Form CORRESP - Correspondence
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Major Issues Report

Form 8-K - Current report
Jul 03, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Correspondence

Form CORRESP - Correspondence
Mar 22, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Major Issues Report

Form 8-K - Current report